Organization (Nonprofit)
National Development and Research Institutes
ClinicalTrials.gov lists National Development and Research Institutes as lead sponsor of 23 trials. It has 3 approved assets.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 0 registered with a 2026 start date. The dashed outline is the pace from the 0 registered with a start date through September, planned starts included, not adjusted; not a forecast. No forecast is made for this organization: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.
This page covers National Development and Research Institutes: 23 lead-sponsored trials and 1 legal-entity registration.
Disease areas (16)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Substance-Related Disorders | 14 |
| Opioid-Related Disorders | 5 |
| Obesity | 4 |
| Hepatitis C | 3 |
| Stress Disorders, Post-Traumatic | 3 |
Showing 5 of 16 disease areas.
Trials by start year as sponsor or collaborator (18)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2023 | 2 |
| 2019 | 1 |
| 2018 | 1 |
| 2017 | 4 |
| 2016 | 2 |
| 2015 | 4 |
| 2014 | 2 |
| 2013 | 3 |
| 2012 | 1 |
| 2011 | 1 |
Showing 10 of 18 years.
Recruitment duration, a model prediction: none of the 23 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Approved assets (3)
Shown in this order: max phase first.
| Drug | Trials |
|---|---|
| Buprenorphine | 2 |
| NALTREXONE | 1 |
| Methadone | 1 |
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 1 of 1 hit target (n=1) | 0 of 1 on time (n=1) |
Journals published in (29)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Brain : a journal of neurology | 3 |
| Journal of substance abuse treatment | 3 |
| Military medicine | 3 |
| Harm reduction journal | 2 |
| Journal of experimental criminology | 2 |
Showing 5 of 29 journals.
Organization relationships (5)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Arizona's Public Universities | Co sponsors trial with | 1 |
| The University of Texas System | Co sponsors trial with | 1 |
| Hanoi Medical University | Co sponsors trial with | 1 |
| Boston University | Co sponsors trial with | 1 |
| University of Puerto Rico | Co sponsors trial with | 1 |
Latest dated events (38)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2023-12-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2023-08-26 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2019-04-05 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2018-01-31 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2017-09-15 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 38 events.
CLIA clinical laboratory certificates (1)
| Lab | Certificate | Status |
|---|---|---|
| NATIONAL DEVELOPMENT & RESEARCH INSTITUTES INC | Certificate of waiver | Terminated |
Biomarker capability evidence (13)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| MICA | Trial sponsor | Named in trial inclusion criteria |
| OGN | Trial collaborator | Named in trial inclusion criteria |
| OGN | Trial sponsor | Named in trial inclusion criteria |
| SEPHS1 | Trial collaborator | Named in trial inclusion criteria |
| INS | Trial collaborator | Named in trial exclusion criteria |
Showing 5 of 13 evidence rows.
Biomarkers this organization publishes on (4)
Shown in this order: most publications first.
On Scientist.com
National Development and Research Institutes is listed as a research supplier in the Scientist.com network.
NDRI (National Development and Research Institutes) performs non profit research in drug/alcohol abuse, HIV, and public health.
- Website
- www.ndri.org
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, and workforce and board diversity, as filed.
Work with National Development and Research Institutes on Scientist.com
For prices, more details, or to contact National Development and Research Institutes, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.